Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 52, Issue 12, Pages 923-931
Publisher
Wiley
Online
2012-07-21
DOI
10.1002/mc.21942
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Polymorphic −844T/C inFasLPromoter Predicts Survival and Relapse in Non–Small Cell Lung Cancer
- (2011) Wen-Wei Sung et al. CLINICAL CANCER RESEARCH
- Combined Effect of Genetic Polymorphisms in P53, P73, and MDM2 on Non-small Cell Lung Cancer Survival
- (2011) Li Liu et al. Journal of Thoracic Oncology
- Association Between Polymorphisms of ERCC1 and XPD and Clinical Response to Platinum-Based Chemotherapy in Advanced Non–Small Cell Lung Cancer
- (2010) Fan Li et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy
- (2010) S Glaysher et al. BRITISH JOURNAL OF CANCER
- Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility
- (2010) Jesús Lascorz et al. CARCINOGENESIS
- Predictive Effects of ERCC1 and XRCC3 SNP on Efficacy of Platinum-based Chemotherapy in Advanced NSCLC Patients
- (2010) C. Zhou et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer
- (2010) Gudrun Knechtel et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients
- (2010) Sara S. Strom et al. LEUKEMIA & LYMPHOMA
- Pharmacogenetics and pharmacogenomics of anticancer agents
- (2009) R. S. Huang et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia
- (2009) D. H. Kim et al. CLINICAL CANCER RESEARCH
- Pharmacogenomics of platinum-based chemotherapy in NSCLC
- (2009) Michelle AT Hildebrandt et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
- (2009) Eray Goekkurt et al. JOURNAL OF CLINICAL ONCOLOGY
- APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells
- (2009) Dong Wang et al. LUNG CANCER
- Regulation of damage recognition in mammalian global genomic nucleotide excision repair
- (2009) Kaoru Sugasawa MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Poly(ADP-ribose) polymerase suppression protects rheumatoid synovial fibroblasts from Fas-induced apoptosis
- (2009) S. Garcia et al. RHEUMATOLOGY
- DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia
- (2008) Bahadır Batar et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now